Optogenetic pain management☆
|AFFILIATION:||Nanoscope Technologies, LLC, Dallas, Texas, United States|
Track: Medical & Biotech
Area: Psychological Health
Tech Readiness: TRL 4
Tech Brief: Our optogenetic technology is based on non-invasive, light-based stimulation of specific neurons for pain management across different pain modalities including sever migraine, phantom pain, chronic back pain and pain due to rheumatoid arthritis.
Value Proposition: The epidemic rise in prevalence of chronic pain in soldiers due to increasing gear is a major concern for our Nation. Further, some Veterans suffers from chronic pain from lasting effects of combat injuries such as a "phantom limb" after an amputation or back or spinal cord damage after an accident. Although there are a range of existing clinical options, a lot of patients don’t respond to any of them, resulting in opioid dependence. Overprescription of opioids for chronic pain is severely costing lives of many defense personnel. Our optogenetic technology will enable non-drug dependent, reliable pain management across different pain modalities including sever migraine, phantom pain, chronic back pain and pain due to rheumatoid arthritis.
Org Type: Corporation
Booth Number: T508